topical treatment

Patient dosing begins for Phase 2 study of new topical gel for atopic dermatitisThe first patient has been dosed in the phase two study of PR022 (hypochlorous acid, Realm Therapeutics), a topical gel treatment for patients with atopic dermatitis.
FDA clears new drug application for topical psoriasis treatmentThe Food and Drug Administration accepted a new drug application for IDP-118 lotion (halobetasol propionate and tazarotene, Ortho Dermatologics), for the topical treatment of plaque psoriasis.
Topical for acne vulgarisOrtho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals.
New products for November 2017A round-up of the latest products hitting the dermatology market including treatment for eczema and wounds, plus care for rejuvenating procedures.
Long-term implant showing potential in glaucoma therapyAn extended-release therapy that encapsulates travoprost in an intracameral implant showed a statistically significant and clinically meaningful reduction in IOP with results comparable to topical once-daily travoprost ophthalmic solution, said Tom R. Walters, MD, Texan Eye, Austin.
Management of drug-induced cicatricial conjunctivitis and dry eyeA 65-year-old male with a history of congenital cataracts, bilateral cataract extraction and secondary placement of anterior chamber intraocular lenses with subsequent development of glaucoma, cicatricial conjunctivitis, dry eye and limbal stem cell deficiency presented with left eye pain and decreased vision.
Pediatric psoriasis, eczema: Triggers and therapiesIn part two of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses environmental and microbial triggers and when to choose systemic therapies with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
Topical treatment warning for orbital soft tissue
Topical treatment warning for orbital soft tissueTopical glaucoma drops have potential for causing profound structural soft-tissue changes.
Fidgetin like 2 identified as promising wound healing targetResearchers have identified the previously uncharacterized microtubule-severing enzyme, Fidgetin-like 2 (FL2), as a potential therapeutic target